Evotec SE ADR

Evotec SE ADR

Yahoo Finance • 4 days ago

3 Founder Led Stocks For October 2026

AI is reshaping how work gets done and the IMF now warns it could eventually affect about 40% of jobs worldwide. That kind of slow moving earthquake favors founders who are still in the cockpit, steering their businesses through the shift... Full story

Yahoo Finance • 17 days ago

Evotec Announces Chief Scientific Officer Transition

Dr. Cord Dohrmann to step down as of September 30, 2026 Search ongoing for a successor HAMBURG, Germany, Sept. 29, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced that Chief Scientific Officer... Full story

Yahoo Finance • 17 days ago

APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES

Giovanni Amabile, Founder and CEOGiovanni Amabile, Founder and CEO of Aptadir Therapeutics Funds will advance novel class of RNA inhibitors to reverse intractable genetic conditions Seed is led by 4BIO Capital with follow-on participation... Full story

Yahoo Finance • 23 days ago

Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market Share

Company Logo Stricter safety rules, drug innovation and CRO outsourcing drive demand, while imaging, CRISPR and data analytics improve testing and reduce animal use. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "In Vivo Toxicology - Global... Full story

Yahoo Finance • 24 days ago

Capitalize on the ADME-Toxicology Testing Shift: Benchmark Charles River, Thermo Fisher, Eurofins, WuXi AppTec and Evotec to Accelerate R&D ROI and Outpace Disruption

Company Logo Demand is rising for faster, accurate ADME-Tox testing, driven by complex biologics, tighter regulation, personalized medicine, and adoption of high-throughput, in vitro and in silico methods. Dublin, Sept. 22, 2026 (GLOBE N... Full story

Yahoo Finance • last month

Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies

First-in-human Phase 1 study initiated for investigational antibodies targeting orthopoxviruses developed under U.S. Department of War Accelerated Antibodies Program Supports development of countermeasures against orthopoxviruses, a high-p... Full story

Yahoo Finance • last month

Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors

Collaboration aims to validate Evotec's proprietary BiTco costimulatory CD2 bispecifics platform in combination with Plectonic's logic-gated DNA-protein immunotherapy technology LOGIBODY® BiTco designed to boost T cell activation by engagi... Full story

Yahoo Finance • 5 months ago

QuickLogic Posts Downbeat Q1 Results, Joins Resideo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures falling around 100 points on Wednesday. Shares of QuickLogic Corp(NASDAQ:QUIK) fell in pre-market trading after the company reported worse-than-expected first-quarter financ... Full story

Yahoo Finance • 5 months ago

Why Nextpower Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Shares of Nextpower Inc(NASDAQ:NXT) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and raised its FY27 sales guidance. The company announced it will acquire assets of Zig... Full story

Yahoo Finance • 5 months ago

Evotec places €116.1M convertible bonds to fund Project Horizon

* Evotec SE (EVO [https://seekingalpha.com/symbol/EVO]) on Tuesday placed senior unsecured convertible bonds due 2033, convertible into new and/or existing no-par value ordinary bearer shares of the company in an aggregate principal amou... Full story

Yahoo Finance • 5 months ago

Evotec Q1 Earnings Call Highlights

Evotec logo Why These 3 Large Caps Are Bucking the August Slump Evotec (NASDAQ:EVO) reported first-quarter 2026 results that management said were shaped by a tough year-over-year comparison, continued softness in early drug discovery dem... Full story

Yahoo Finance • 5 months ago

Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall

Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelines Collaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D capabilities and Almirall... Full story

Yahoo Finance • 6 months ago

H.C. Wainwright Initiates Coverage of Evotec (EVO) with a Buy Rating

Evotec SE (NASDAQ:EVO) is one of the 10 Best Penny Stocks to Buy and Hold Under $5. On April 14, 2026, H.C. Wainwright assumed coverage of Evotec SE (NASDAQ:EVO) with a Buy rating and a $7 price target, citing the company’s shift from a... Full story

Yahoo Finance • 6 months ago

Evotec Q4 Earnings Call Highlights

Evotec logo Key Points Horizon transformation: Evotec is implementing a major operating overhaul to cut its site footprint from 14 to 10 and reduce about 800 positions, targeting roughly EUR 75 million in structural run-rate savings by e... Full story

Yahoo Finance • 6 months ago

Quant snapshot: Delta Air Lines leads top-rated names as Byrna Technologies, Simulations Plus lag

Quant rankings for the upcoming earnings calendar show strength concentrated in industrials and select consumer staples and technology names, while weakness is more pronounced across industrials, health care, and materials. A total of 56 c... Full story

Yahoo Finance • 6 months ago

3 European Dividend Stocks Yielding Up To 8.2%

As European markets experience a resurgence, with the STOXX Europe 600 Index climbing 3.92% amid easing concerns over Middle East conflicts, investors are increasingly drawn to dividend stocks as a source of steady income amidst inflationa... Full story

Yahoo Finance • 6 months ago

3 European Dividend Stocks Yielding At Least 3.1%

The European market has been navigating a challenging landscape, with the pan-European STOXX Europe 600 Index showing modest gains amid uncertainties surrounding the Middle East conflict and its potential impact on economic growth. As inve... Full story

Yahoo Finance • 8 months ago

3 European Dividend Stocks Yielding Up To 5.3%

As European markets navigate volatility, with the STOXX Europe 600 Index recently hitting a new high before settling nearly unchanged, investors are keenly observing economic indicators such as employment growth and GDP expansion in the eu... Full story

Yahoo Finance • 8 months ago

European Dividend Stocks To Consider In February 2026

As European markets continue to show resilience amid global volatility, optimism about the eurozone economy has bolstered investor sentiment, with major indices like the STOXX Europe 600 reaching new highs. In this environment, dividend st... Full story

Yahoo Finance • 8 months ago

Top European Dividend Stocks To Watch In February 2026

As the eurozone economy continues its modest recovery with strengthened confidence and investment, European markets have shown resilience despite mixed performances among major stock indexes. In this environment, dividend stocks can offer... Full story